A Regenstrief Institute research scientist has helped author new national guidelines to reduce the risk of a second stroke.
Neurologist Linda Williams, M.D., is a member of the American Heart Association writing group for the updated guideline titled “2021 Guideline for the Prevention of Stroke in Patients with Stroke and Transient Ischemic Attack.” In addition to her role at Regenstrief, Dr. Williams is affiliated with the U.S. Department of Veterans Affairs and Indiana University School of Medicine.
The new guideline encourages providers to tailor stroke prevention strategies based on the cause of the stroke.
Dr. Williams is an experienced neurologist who has conducted extensive research on stroke and TIA care. In this report, she authored the sections on homocysteine, embolic stroke of undetermined source and the use of antithrombotic medications.
As a writing group member, Dr. Williams reviewed all sections of the guidelines. This update is the first since 2014.
About Linda Williams, M.D.
In addition to her role as a research scientist at Regenstrief, Linda S. Williams, M.D., is a core investigator for the U.S. Department of Veterans Affairs Health Services Research and Development Center for Health Information and Communication, Richard L. Roudebush VA Medical Center. She also is a professor of neurology at Indiana University School of Medicine.
